293 related articles for article (PubMed ID: 19168602)
1. The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis.
Feys P; D'hooghe MB; Nagels G; Helsen WF
Mult Scler; 2009 Mar; 15(3):371-8. PubMed ID: 19168602
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam in primary orthostatic tremor: a double-blind placebo-controlled crossover study.
Hellriegel H; Raethjen J; Deuschl G; Volkmann J
Mov Disord; 2011 Nov; 26(13):2431-4. PubMed ID: 21953629
[TBL] [Abstract][Full Text] [Related]
3. Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor.
Handforth A; Martin FC
Mov Disord; 2004 Oct; 19(10):1215-21. PubMed ID: 15390011
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
[TBL] [Abstract][Full Text] [Related]
5. The effect of levetiracetam on essential tremor.
Bushara KO; Malik T; Exconde RE
Neurology; 2005 Mar; 64(6):1078-80. PubMed ID: 15781835
[TBL] [Abstract][Full Text] [Related]
6. Levetiracetam is not effective for essential tremor.
Elble RJ; Lyons KE; Pahwa R
Clin Neuropharmacol; 2007; 30(6):350-6. PubMed ID: 18090460
[TBL] [Abstract][Full Text] [Related]
7. Levetiracetam for phasic spasticity in multiple sclerosis.
Hawker K; Frohman E; Racke M
Arch Neurol; 2003 Dec; 60(12):1772-4. PubMed ID: 14676055
[TBL] [Abstract][Full Text] [Related]
8. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
[TBL] [Abstract][Full Text] [Related]
9. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.
Nutt JG; Carter JH; Carlson NE
Arch Neurol; 2007 Mar; 64(3):319-23. PubMed ID: 17353373
[TBL] [Abstract][Full Text] [Related]
10. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
[TBL] [Abstract][Full Text] [Related]
11. Digitised spirography as an evaluation tool for intention tremor in multiple sclerosis.
Feys P; Helsen W; Prinsmel A; Ilsbroukx S; Wang S; Liu X
J Neurosci Methods; 2007 Mar; 160(2):309-16. PubMed ID: 17113154
[TBL] [Abstract][Full Text] [Related]
12. Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using meta-analytic techniques.
Richy FF; Banerjee S; Brabant Y; Helmers S
Epilepsy Behav; 2009 Oct; 16(2):240-5. PubMed ID: 19699156
[TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled trial of levetiracetam in central pain in multiple sclerosis.
Falah M; Madsen C; Holbech JV; Sindrup SH
Eur J Pain; 2012 Jul; 16(6):860-9. PubMed ID: 22337561
[TBL] [Abstract][Full Text] [Related]
14. Memantine induces reversible neurologic impairment in patients with MS.
Villoslada P; Arrondo G; Sepulcre J; Alegre M; Artieda J
Neurology; 2009 May; 72(19):1630-3. PubMed ID: 19092106
[TBL] [Abstract][Full Text] [Related]
15. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study.
Ramael S; Daoust A; Otoul C; Toublanc N; Troenaru M; Lu ZS; Stockis A
Epilepsia; 2006 Jul; 47(7):1128-35. PubMed ID: 16886975
[TBL] [Abstract][Full Text] [Related]
16. A double blind randomized placebo control trial of levetiracetam in Tourette syndrome.
Smith-Hicks CL; Bridges DD; Paynter NP; Singer HS
Mov Disord; 2007 Sep; 22(12):1764-70. PubMed ID: 17566124
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome.
Hedderick EF; Morris CM; Singer HS
Pediatr Neurol; 2009 Jun; 40(6):420-5. PubMed ID: 19433274
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam and bleeding disorders.
Boon P; Hulhoven R; Offner F
Acta Neurol Belg; 2007 Dec; 107(4):97-102. PubMed ID: 18416281
[TBL] [Abstract][Full Text] [Related]
20. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.
Aragona M; Onesti E; Tomassini V; Conte A; Gupta S; Gilio F; Pantano P; Pozzilli C; Inghilleri M
Clin Neuropharmacol; 2009; 32(1):41-7. PubMed ID: 18978501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
